Future projects employing the ISET® methodology for patients with breast cancer without brain metastases should include research on other factors associated with initial metastasis, such as EpCAM and TGF-β R1, simultaneous analysis of gene expression related to tumor progression, and aspects of the tumor microenvironment and the immune system. Here, EPCAM is linked to breast carcinoma.